{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:28:58Z","timestamp":1790710138265,"version":"4.1.0"},"reference-count":93,"publisher":"American Society for Clinical Investigation","issue":"14","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01-AI114780,R21-AI142198,R01-AI104739"],"award-info":[{"award-number":["R01-AI114780,R21-AI142198,R01-AI104739"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"crossref","award":["MDA575198"],"award-info":[{"award-number":["MDA575198"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,23]]},"abstract":"<jats:p>Rituximab, a B cell\u2013depleting therapy, is indicated for treating a growing number of autoantibody-mediated autoimmune disorders. However, relapses can occur after treatment, and autoantibody-producing B cell subsets may be found during relapses. It is not understood whether these autoantibody-producing B cell subsets emerge from the failed depletion of preexisting B cells or are generated de novo. To further define the mechanisms that cause postrituximab relapse, we studied patients with autoantibody-mediated muscle-specific kinase (MuSK) myasthenia gravis (MG) who relapsed after treatment. We carried out single-cell transcriptional and B cell receptor profiling on longitudinal B cell samples. We identified clones present before therapy that persisted during relapse. Persistent B cell clones included both antibody-secreting cells and memory B cells characterized by gene expression signatures associated with B cell survival. A subset of persistent antibody-secreting cells and memory B cells were specific for the MuSK autoantigen. These results demonstrate that rituximab is not fully effective at eliminating autoantibody-producing B cells and provide a mechanistic understanding of postrituximab relapse in MuSK MG.<\/jats:p>","DOI":"10.1172\/jci.insight.136471","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T12:29:35Z","timestamp":1592915375000},"source":"Crossref","is-referenced-by-count":70,"title":["Single-cell repertoire tracing identifies rituximab-resistant B cells during myasthenia gravis relapses"],"prefix":"10.1172","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-082X","authenticated-orcid":true,"given":"Ruoyi","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Immunobiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-4103","authenticated-orcid":true,"given":"Miriam L.","family":"Fichtner","sequence":"additional","affiliation":[{"name":"Department of Immunobiology and"},{"name":"Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth B.","family":"Hoehn","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0234-4790","authenticated-orcid":true,"given":"Minh C.","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Immunobiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Stathopoulos","sequence":"additional","affiliation":[{"name":"Department of Immunobiology and"},{"name":"Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8438-482X","authenticated-orcid":true,"given":"Richard J.","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4957-1544","authenticated-orcid":true,"given":"Steven H.","family":"Kleinstein","sequence":"additional","affiliation":[{"name":"Department of Immunobiology and"},{"name":"Interdepartmental Program in Computational Biology & Bioinformatics, Yale University, New Haven, Connecticut, USA."},{"name":"Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"Department of Immunobiology and"},{"name":"Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"issue":"5","key":"B1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20061"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/85520"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81251-9"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080695"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.21778"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706383"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909169"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1756285611411503"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.04.039"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303664"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.4190"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.220475"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22006"},{"issue":"17","key":"B15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94263","article-title":"Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis","volume":"2","author":"Stathopoulos","year":"2017","journal-title":"JCI Insight"},{"issue":"12","key":"B16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127167","article-title":"Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients","volume":"4","author":"Takata","year":"2019","journal-title":"JCI Insight"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001074107"},{"issue":"12","key":"B18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93222","article-title":"Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab","volume":"2","author":"Cho","year":"2017","journal-title":"JCI Insight"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.2154"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-043414"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/art.22810"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128269"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601850"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.1.198"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.11.1747"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/art.22603"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-307819"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13024"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.031"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0769-8"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/335440a0"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81902-9"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl010"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0082-z"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13535"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182407982"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/ar4481"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1595-3"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aan8289"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01901-w"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211191"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1091-1","article-title":"A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study","volume":"18","author":"Stradner","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.080960"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/art.30466"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/ar2798"},{"issue":"175","key":"B46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.11.006"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.065656"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev005"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/ni829"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/ni1434"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20032000"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.11.035"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/path.4346"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025687"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.03.003"},{"issue":"4","key":"B57","first-page":"490","article-title":"Sequential therapy with belimumab followed by rituximab in Sj\u00f6gren\u2019s syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy","volume":"32","author":"De Vita","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25657"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050064"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205474"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key428"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/art.21617"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-123844"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6756"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav1648"},{"issue":"12","key":"B66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000540","article-title":"Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing","volume":"1","author":"Boyd","year":"2009","journal-title":"Sci Transl Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1323862111"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2014.0239"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1525510113"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11049-4"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1362-5"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1285-1"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3231"},{"issue":"6","key":"B74","article-title":"Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis","volume":"4","author":"Greenfield","year":"2019","journal-title":"JCI Insight"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty235"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900666"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31817-3"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601415"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu138"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4096"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07242-6"},{"issue":"Web Server issue","key":"B82","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B83","doi-asserted-by":"crossref","unstructured":"Linderman GC, Zhao J, Kluger Y. Zero-preserving imputation of scRNA-seq data using low-rank approximation. bioRxiv. https:\/\/doi.org\/10.1101\/397588 Published August 22, 2018. Accessed June 18, 2020","DOI":"10.1101\/397588"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1530509100"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377"},{"key":"B86","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http:\/\/www.R-project.org\/ Accessed June 18, 2020"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2307\/1934352"},{"key":"B88","first-page":"261","article-title":"SciPy 1.0--fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Med"},{"key":"B89","first-page":"164","article-title":"PHYLIP - Phylogeny Inference Package (Version 3.2)","volume":"5","author":"Felsenstein","year":"2004","journal-title":"Cladistics"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1137\/0128004"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1906020116"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty633"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/2041-210X.12628"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/136471\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:12:10Z","timestamp":1779192730000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/136471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":93,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2020,7,23]]},"published-print":{"date-parts":[[2020,7,23]]}},"alternative-id":["10.1172\/jci.insight.136471"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.136471","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/840389","asserted-by":"object"}]},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"article-number":"e136471"}}